Nanomedicines and Vaccines
NANO-VAC
French Institute of Health and Medical Research
París, FranciaFrench Institute of Health and Medical Research-ko ikertzaileekin lankidetzan egindako argitalpenak (9)
2021
2020
-
IgE allergy diagnostics and other relevant tests in allergy, a World Allergy Organization position paper
World Allergy Organization Journal, Vol. 13, Núm. 2
2008
-
Influence of ligand valency on the targeting of immature human dendritic cells by mannosylated liposomes
Bioconjugate Chemistry, Vol. 19, Núm. 12, pp. 2385-2393
2005
-
Albumin nanoparticles for the intravitreal delivery of anticytomegaloviral drugs
Mini-Reviews in Medicinal Chemistry, Vol. 5, Núm. 3, pp. 293-305
2004
-
Synthesis of thiol-reactive lipopeptide adjuvants. Incorporation into liposomes and study of their mitogenic effect on mouse splenocytes
Bioconjugate Chemistry, Vol. 15, Núm. 3, pp. 541-553
2002
-
Adaptive immune responses of legumin nanoparticles
Journal of Drug Targeting, Vol. 10, Núm. 8, pp. 625-631
-
Efficacy of ganciclovir-loaded nanoparticles in human cytomegalovirus (HCMV)-infected cells
Journal of Drug Targeting, Vol. 10, Núm. 3, pp. 231-238
-
Ocular disposition and tolerance of ganciclovir-loaded albumin nanoparticles after intravitreal injection in rats
Biomaterials, Vol. 23, Núm. 7, pp. 1587-1594
2000
-
Development of a sensitive method for the determination of ganciclovir by reversed-phase high-performance liquid chromatography
Journal of Chromatography A, Vol. 870, Núm. 1-2, pp. 159-167